1、 CHOP, cyclophosphamide, doxorubicin, prednisone, vincristine; DLBCL, diffuse large B-cell lymphoma; FFPET, formalin-fixed paraffin-embedded tissue; FFS, failure-free survival; OS, overall survival; R, rituximab. CHOP, cyclophosphamide, doxorubicin, prednisone, vincristine; DLBCL, diffuse large B-ce
2、ll lymphoma; FFS, failure-free survival; OS, overall survival; R, rituximab.CHOP, cyclophosphamide, doxorubicin, prednisone, vincristine; DLBCL, diffuse large B-cell lymphoma; FFS, failure-free survival; OS, overall survival; R, rituximab; Yrs, years. CHOP, cyclophosphamide, doxorubicin, prednisone,
3、 vincristine; DLBCL, diffuse large B-cell lymphoma; HR, hazard ratio; IPI, International Prognostic Index; OS, overall survival; R, rituximab; yrs, years. CHOP, cyclophosphamide, doxorubicin, prednisone, vincristine; DLBCL, diffuse large B-cell lymphoma; GCB, germinal center B-cell like; HR, hazard ratio; IPI, International Prognostic Index; R, rituximab; yrs, years. .DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; MALT, mucosa-associated lymphoid tissue; MCL, mantle-cell lymphoma.
